Publication:

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

Simple item page
cris.lastimport.scopus

2024-08-07T10:44:59Z

cris.legacyId

278142

cris.virtual.author-scopus

21935503000

cris.virtual.department

LVG

cris.virtual.parent-organization

GHI

cris.virtual.parent-organization

SV

cris.virtual.parent-organization

EPFL

cris.virtual.sciperId

167919

cris.virtual.unitId

11172

cris.virtual.unitManager

Trono, Didier

cris.virtualsource.author-scopus

0b08330c-5e49-45c8-ae1b-fdb89fe9015d

cris.virtualsource.department

0b08330c-5e49-45c8-ae1b-fdb89fe9015d

cris.virtualsource.orcid

0b08330c-5e49-45c8-ae1b-fdb89fe9015d

cris.virtualsource.parent-organization

f2ab561d-e10b-493d-959a-e176ae6e6a28

cris.virtualsource.parent-organization

f2ab561d-e10b-493d-959a-e176ae6e6a28

cris.virtualsource.parent-organization

f2ab561d-e10b-493d-959a-e176ae6e6a28

cris.virtualsource.parent-organization

f2ab561d-e10b-493d-959a-e176ae6e6a28

cris.virtualsource.rid

0b08330c-5e49-45c8-ae1b-fdb89fe9015d

cris.virtualsource.sciperId

0b08330c-5e49-45c8-ae1b-fdb89fe9015d

cris.virtualsource.unitId

f2ab561d-e10b-493d-959a-e176ae6e6a28

cris.virtualsource.unitManager

f2ab561d-e10b-493d-959a-e176ae6e6a28

datacite.rights

metadata-only

dc.contributor.author

Stringhini, Silvia

dc.contributor.author

Wisniak, Ania

dc.contributor.author

Piumatti, Giovanni

dc.contributor.author

Azman, Andrew S

dc.contributor.author

Lauer, Stephen A

dc.contributor.author

Baysson, Hélène

dc.contributor.author

De Ridder, David

dc.contributor.author

Petrovic, Dusan

dc.contributor.author

Schrempft, Stephanie

dc.contributor.author

Marcus, Kailing

dc.contributor.author

Yerly, Sabine

dc.contributor.author

Arm Vernez, Isabelle

dc.contributor.author

Keiser, Olivia

dc.contributor.author

Hurst, Samia

dc.contributor.author

Posfay-Barbe, Klara M

dc.contributor.author

Trono, Didier

dc.contributor.author

Pittet, Didier

dc.contributor.author

Gétaz, Laurent

dc.contributor.author

Chappuis, François

dc.contributor.author

Eckerle, Isabella

dc.date.accessioned

2020-06-19T13:14:22

dc.date.available

2020-06-19T13:14:22

dc.date.created

2020-06-19

dc.date.issued

2020-06-11

dc.date.modified

2025-01-23T14:19:37.188458Z

dc.description.abstract

Assessing the burden of COVID-19 on the basis of medically attended case numbers is suboptimal given its reliance on testing strategy, changing case definitions, and disease presentation. Population-based serosurveys measuring anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) antibodies provide one method for estimating infection rates and monitoring the progression of the epidemic. Here, we estimate weekly seroprevalence of anti-SARS-CoV-2 antibodies in the population of Geneva, Switzerland, during the epidemic.

dc.description.sponsorship

LVG

dc.identifier.doi

10.1016/S0140-6736(20)31304-0

dc.identifier.uri

https://infoscience.epfl.ch/handle/20.500.14299/169465

dc.relation.journal

The Lancet

dc.title

Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study

dc.type

text::journal::journal article::research article

dspace.entity.type

Publication

dspace.legacy.oai-identifier

oai:infoscience.epfl.ch:278142

epfl.curator.email

jorge.rodriguesdematos@epfl.ch

epfl.lastmodified.email

jorge.rodriguesdematos@epfl.ch

epfl.legacy.itemtype

Journal Articles

epfl.legacy.submissionform

ARTICLE

epfl.oai.currentset

OpenAIREv4

epfl.oai.currentset

SV

epfl.oai.currentset

article

epfl.peerreviewed

REVIEWED

epfl.publication.version

http://purl.org/coar/version/c_970fb48d4fbd8a85

epfl.writtenAt

EPFL

oaire.citation.endPage

319

oaire.citation.issue

10247

oaire.citation.startPage

313

oaire.citation.volume

396

Files

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Journal articles